March 2026
The global UTI drugs market size was evaluated at USD 5.06 billion in 2025 and is predicted to hit around USD 8.65 billion by 2035, growing at a CAGR of 5.50%.
March 2026
The global over the counter (OTC) drugs market size was valued at USD 135.25 billion in 2025 and is expected to hit around USD 256.87 billion by 2035, growing at a CAGR of 6.62%.
March 2026
The global muscle relaxant drugs market size is estimated to hit around USD 7.64 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 4.76%.
February 2026
The global anti-epileptic drugs for pediatrics market size is estimated to hit around USD 3.25 billion by 2035 increasing from USD 1.50 billion in 2025, with a CAGR of 8.04%.
February 2026
The global S1P receptor modulator drugs market size is estimated to hit around USD 6.96 billion by 2035 increasing from USD 3.16 billion in 2025, with a CAGR of 8.22%.
February 2026
The global companion animal drugs market size was evaluated at USD 15.77 billion in 2025 and is projected to reach around USD 29.42 billion by 2035, at a CAGR of 6.43%.
February 2026
The global pain management drugs market size was calculated at USD 87.19 billion in 2025 and is predicted to increase from USD 90.50 billion in 2026 to approximately USD 130.80 billion by 2034, expanding at a CAGR of 4.14% from 2025 to 2034.
February 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 1.86 billion in 2025 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
February 2026
The global ophthalmic drugs market size accounted for USD 45.35 billion in 2025 and is expected to exceed USD 75.79 billion by 2035, growing at a CAGR of 5.27% from 2026 to 2035.
February 2026
The global antiepileptic drugs market size was evaluated at USD 18.03 billion in 2025 and is predicted to hit around USD 30.80 billion by 2035, growing at a CAGR of 5.50%.
February 2026
The global sedative-hypnotic drugs market size was evaluated at USD 15.64 billion in 2025 and is predicted to hit around USD 31.94 billion by 2035, growing at a CAGR of 7.40%.
February 2026
The global pingueculum drugs market size was evaluated at USD 832.14 million in 2025 and is predicted to hit around USD 1,660.04 million by 2035, growing at a CAGR of 7.15%.
February 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 20.17 billion in 2025, with a CAGR of 14.63%.
February 2026
The global antitussive drugs market size was evaluated at USD 1.72 billion in 2025 and is predicted to hit around USD 2.86 billion by 2035, growing at a CAGR of 5.23%.
February 2026
The global expectorant drugs market size was evaluated at USD 18.67 billion in 2025 and is predicted to hit around USD 29.72 billion by 2035, growing at a CAGR of 4.76%.
February 2026
The global performance enhancing drugs market size was evaluated at USD 436.07 million in 2025 and is predicted to hit around USD 892.09 million by 2035, growing at a CAGR of 7.42%.
February 2026
The global anthelmintic drugs market size was calculated at USD 4.06 billion in 2025 and is predicted to increase from USD 4.4 billion in 2026 to approximately USD 9.01 billion by 2035, expanding at a CAGR of 8.30% from 2026 to 2035.
February 2026
The global asthma drugs market size is calculated at USD 26.49 billion in 2025 and is predicted to increase from USD 27.87 billion in 2026 to approximately USD 42.74 billion by 2035, expanding at a CAGR of 4.46% from 2026 to 2035.
February 2026
The global cytotoxic drugs market size was calculated at USD 18.10 billion in 2025 and is expected to reach around USD 30.39 billion by 2035, expanding at a CAGR of 5.32% from 2026 to 2035. The growing prevalence of the cancer that fueling the growth of the market.
February 2026
The U.S. generic drugs market size was estimated at USD 146.04 billion in 2025 and is predicted to increase from USD 153.40 billion in 2026 to approximately USD 243.70 billion by 2035, expanding at a CAGR of 5.25% from 2026 to 2035.
February 2026
The antihypertensive drugs market size is valued at USD 25.50 billion in 2025 and is expected to be worth around USD 37.29 billion by 2035 with a CAGR of 3.87%.
January 2026
The global infertility drugs market size surpassed USD 4.18 billion in 2025 and is projected to hit around USD 7.50 billion by 2035, growing at a CAGR of 6.02%.
January 2026
The global asthma and COPD drugs market size was estimated at USD 43.49 billion in 2025 and is expected to hit USD 92.39 billion by 2035, with a CAGR of 7.83%.
January 2026
The global generic drugs market size is calculated at USD 468.08 billion in 2025 and is predicted to increase from USD 491.67 billion in 2026 to approximately USD 762.48 billion by 2035, expanding at a CAGR of 5% from 2026 to 2035.
January 2026
The global atopic dermatitis drug market size is calculated at USD 15.92 billion in 2025 and is predicted to increase from USD 17.21 billion in 2026 to approximately USD 33.42 billion by 2035, expanding at a CAGR of 7.70% from 2026 to 2035.
January 2026
The global veterinary dermatology drugs market size is calculated at USD 8.96 billion in 2025 and is projected to hit around USD 20.62 billion by 2035 with a CAGR of 8.69%.
January 2026
The global pediatric drugs market size is calculated at USD 163.28 billion in 2025 and is predicted to increase from USD 183.20 billion in 2026 to approximately USD 506.52 billion by 2035, expanding at a CAGR of 11.99% from 2026 to 2035.
December 2025
The global cancer supportive care drugs market size is projected to hit around USD 27.45 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 2.09%.
December 2025
The global nephrology drugs market size is accounted at USD 18.68 billion in 2025 and predicted to increase from USD 19.71 billion in 2026 to approximately USD 31.83 billion by 2035, representing a CAGR of 5.47% from 2026 to 2035.
December 2025
The global uterine fibroid drugs market size is evaluated at USD 3.16 billion in 2025 and is predicted to hit around USD 11.93 billion by 2035, growing at a CAGR of 14.21%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com